Crosslink Capital’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
CI
AE
CCPM
Crosslink Capital's CLBT Position: Q3 2025 in Review
Crosslink Capital sold out of Cellebrite (CLBT) in Q3 2025, closing a stake of 696,744 shares — an estimated $11.1M sold.
Crosslink Capital first reported a position in CLBT in Q3 2021 and held it in 16 quarters. The position peaked at $66.6M in Q4 2024. 197 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.
- Crosslink Capital reported no remaining Cellebrite position as of Q3 2025 after selling out during the quarter.
- Crosslink Capital sold 696,744 Cellebrite shares in Q3 2025, an estimated $11.1M.
- Crosslink Capital first reported a position in Cellebrite in Q3 2021 and held it in 16 quarters.
- Crosslink Capital's Cellebrite position peaked at $66.6M in Q4 2024.
- 197 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.
Based on Crosslink Capital's 13F filing for Q3 2025, filed 14 Nov 2025.